News After phase 3 hit, Spine seeks path forward for pain drug The first phase 3 readout with Spine BioPharma's drug candidate for chronic low back pain has proved disappointing.
News ViiV's Waterhouse exits to take the CEO job at CSL CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
